Date: 2016-08-16
Type of information: Opening of new premises
Compound:
Company: Avacta (UK)
Therapeutic area: Diagnostic
Type agreement: opening of new premises
Action mechanism:
Disease:
Details: * On August 16, 2016, Avacta , the developer of Affimer® biotherapeutics and research reagents, announced it has opened two new facilities, in Cambridge and Wetherby, Yorkshire. The new buildings almost double Avacta’s overall footprint, which increases from 9,500 to 18,500 sq ft, including new state-of-the-art laboratory facilities. The new laboratories and office space have been established to allow for operations at both sites to expand to meet increasing commercial demands and accommodate Avacta’s growing R&D programme.
The new Cambridge site is located on the Lion Works Business Park in Whittlesford, and covers 5,500 sq ft, of which ~70% houses laboratories. In Wetherby, the Thorp Arch Estate has provided a new 13,000 sq ft building which Avacta has fitted with offices and laboratories accommodating around 60 FTEs.
Financial terms:
Latest news:
